Risk factors for neuroendocrine tumors in Bavaria
Part of Cancer, Digestive system clinical trials.
This study looks at medical records from people in Bavaria to find out what might increase the risk of developing neuroendocrine neoplasms (a rare type of tumor). By reviewing routine health data, researchers hope to discover early signs or risk factors that could help with future detection and care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You live in Bavaria, Germany
- You have statutory (public) health insurance
- You had at least one visit to a doctor, clinic, or outpatient center between 2021 and 2023
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study aims to find genetic causes of neuroendocrine tumors in Mexican patients. By understanding your DNA, researchers hope to improve diagnosis and treatment for people with these rare conditions.
This study looks at better ways to predict disease and choose treatment for cancers of the cervix, endometrium (uterine lining), or uterine sarcoma. It may help patients by testing tools and treatment models that could guide care more accurately.
This trial is a non-treatment registry that collects information about people with metastatic breast cancer in Austria. It may help researchers better understand the disease and outcomes over time by tracking real-world patient details.
This study sets up a national registry to collect information about people with neuroendocrine tumors. It helps researchers understand these cancers better and improve care over time.
This study keeps a worldwide record of people with neuroendocrine tumors to learn about care patterns and outcomes. It may help your doctors and future patients by improving how these tumors are monitored and treated.
This study looks at neuroendocrine tumors by collecting tissue (when available) and tracking how the disease behaves over time. It may help researchers better understand these cancers, including rare cases of adrenocortical cancer.
Hear when a new Neuroendocrine Neoplasm of Lung trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.